Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT
Delay in B-lymphocyte recovery and function followingrituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML
HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study
A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT
Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome
Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation
Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?